search
Wegovy
Trends
- 1Doctors warn of heat risks for GLP-1 drug users▼Amid heat wave, doctors warn of health risks for people taking GLP-1 drugs
As a heat wave grips much of the United States, doctors are warning that people taking GLP-1 medications, such as Ozempic and Wegovy, may face heightened health risks. These drugs can contribute to dehydration, which raises the danger of heat exhaustion and other heat-related illness. Health professionals are advising patients on GLP-1 therapies to drink plenty of fluids, limit strenuous outdoor activity, and watch for warning signs like dizziness and nausea during extreme temperatures.
- 2Weight-loss jab maker's Vogue World sponsorship draws criticism●‘It’s problematic’: concern as weight-loss jab maker sponsors Vogue World event
Novo Nordisk, maker of the weight-loss injection Wegovy, is sponsoring Vogue's World event, prompting concern from health commentators who call the tie-up between a diet drug manufacturer and a leading fashion magazine problematic. Critics argue it glamorises medical weight loss at a publication long associated with narrow beauty standards, raising questions about commercial influence on body image messaging.